Video

Dr Gail Wilensky: Senate Health Bill Will Be to the Left of the House

While there is a lot of uncertainty about what the final Senate healthcare reform bill will look like, Gail Wilensky, PhD, of Project HOPE, expects the bill will ultimately be to the left of the House bill in order to get the moderates on board.

While there is a lot of uncertainty about what the final Senate healthcare reform bill will look like, Gail Wilensky, PhD, of Project HOPE, expects the bill will ultimately be to the left of the House bill in order to get the moderates on board.

Transcript

What is your best prediction for what sort of healthcare legislation the Senate might end up passing (regardless of whether or not it can pass the House)?

My expectation is that they will be a little gentler on the changes to Medicaid than the House were. Not so much about moving to a per capita block grant; I think that can be justified if you had the proper baseline, and you had the proper growth rates, but you can’t take $880 billion out of the program and not do serious damage.

My assumption has been that the Senate legislation is to the left of the House because of the need to make sure the moderates stayed on board, but the conservatives are also pushing to not, in fact, undo the substantial reductions from Medicaid, and their participation is very important as well. So I’m not quite sure where the Senate is going to end up. When you have a 52 to 48 vote—and at the moment it doesn’t look like there’s going to be any bipartisan support on this package at least—it means you can only afford to lose 2 members and after that you’re in serious trouble.

Related Videos
Kenny Cole, MD
Joseph Saseen, PharmD
Bridgette Picou, LVN, ACLPN, The Well Project
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Richard Nowak, MD, MS, Yale School of Medicine
AMCP Recap 2025
Giulio Cossu, MD
Andrew Evens, DO
Lynae Darbes, PhD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo